Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00027869
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
RWJ | CYCLOPENTANECARBOXYLIC ACID [1- (BENZOTHIAZOLE-2-CARBONYL)-4-GUANIDINO- BUTYL]-AMIDE | A | 1QCP | 0.72 |  |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.76 | |
OIS | (S)-N-((2S,3R)-3-HYDROXY-4-(4-((E)- (HYDROXYIMINO)METHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)- 1-PHENYLBUTAN-2-YL)-3-METHYL-2- (3-((2-METHYLTHIAZOL-4-YL)METHYL)- 2-OXOIMIDAZOLIDIN-1-YL)BUTANAMIDE | A | 1YT9 | 0.71 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDI | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDX | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUX | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1MAR | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DV0 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDM | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDB | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PD5 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ9 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUZ | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDF | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVO | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVN | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ8 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HV5 | 0.71 | |
| ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1FRB | 0.71 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.77 | |
L1A | N-(MORPHOLIN-4-YLSULFONYL)-L-PHENYLALANYL- 3-(2-AMINO-1,3-THIAZOL-4-YL)-N- {(1R,2R,3S)-1-[(1R)-CYCLOHEX-3- EN-1-YLMETHYL]-2,3-DIHYDROXY-5- METHYLHEXYL}-L-ALANINAMIDE | A,B | 2G20 | 0.71 | |
MZ6 | N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-3-HYDROXYBENZAMIDE | A,B | 2QI4 | 0.72 | |
RIT | RITONAVIR | A,B | 2B60 | 0.71 | |
| RIT | RITONAVIR | B,D | 1N49 | 0.71 | |
| RIT | RITONAVIR | A | 1RL8 | 0.71 | |
| RIT | RITONAVIR | B | 1SH9 | 0.71 | |
| RIT | RITONAVIR | B | 1HXW | 0.71 | |
MN8 | 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE | N | 1NLP | 0.71 | |
MZ8 | N-{(1S,2R)-3-[(1,3-BENZOTHIAZOL- 6-YLSULFONYL)(ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYL}-3-HYDROXYBENZAMIDE | A,B | 2QI6 | 0.71 | |